ArticleBMC geriatrics2026
Frailty in older adults with type 2 diabetes: the importance of metabolic control and treatment adherence.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFrailty is frequent in older adults with type 2 diabetes and may be associated with negatively affect treatment adherence and metabolic control.
objectiveThis study aimed to assess frailty levels in older adults with type 2 diabetes and to examine their associations with treatment adherence and metabolic parameters.
methodsThis descriptive correlational study was conducted with 384 type 2 diabetes. Data were collected using “Personal Information Form”, “Edmonton Frail Scale (EFS)”, “Medication Adherence Report Scale (MARS)”, and “Metabolic Parameters Monitoring Form”. Descriptive statistics, correlation analyses and multiple linear regression analyses were performed.
resultsFrailty levels were significantly higher among women, those with lower education, longer disease duration, insulin or OAD+insulin users, and individuals with complications. Frailty was observed in 78.6% of participants, with 32.8% classified as severe. The mean MARS score was 14.3, indicating moderate adherence, which was lower among those with complications and OAD+insulin therapy. EFS scores showed significant associations with metabolic parameters and a negative correlation with MARS, suggesting reduced adherence with increasing frailty. Multiple regression confirmed the model predicting frailty was significant (F = 16.170, p < 0.001), explaining 28% of the variance (R²=0.28).
conclusionFrailty is highly prevalent among older adults with type 2 diabetes and is associated with lower medication adherence and adverse metabolic profiles. These findings underscore the importance of routine frailty screening and individualized, multidisciplinary care in diabetes management. IMPLICATIONS OF THE STUDY: Early identification of frailty in older adults with type 2 diabetes is essential to improve treatment adherence and metabolic outcomes. Integrating frailty screening into routine diabetes care can guide personalized interventions and support multidisciplinary management to reduce complications and enhance overall well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.